These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 2994217)

  • 1. The epidemiology of AIDS: current status and future prospects.
    Curran JW; Morgan WM; Hardy AM; Jaffe HW; Darrow WW; Dowdle WR
    Science; 1985 Sep; 229(4720):1352-7. PubMed ID: 2994217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology and prevention of the acquired immunodeficiency syndrome.
    Curran JW
    Ann Intern Med; 1985 Nov; 103(5):657-62. PubMed ID: 2996395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological trends of AIDS in the United States.
    Curran JW; Morgan WM; Starcher ET; Hardy AM; Jaffe HW
    Cancer Res; 1985 Sep; 45(9 Suppl):4602s-4604s. PubMed ID: 2990692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
    N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to acquired immune deficiency syndrome (AIDS)-associated virus (HTLV-III/LAV) in Venezuelan populations.
    Volsky DJ; Rodriguez L; Dewhurst S; Sinangil F; Sakai K; Merino F; Esparza B; De Salvo L
    AIDS Res; 1986; 2(2):79-92. PubMed ID: 3013223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members.
    Goedert JJ; Biggar RJ; Weiss SH; Eyster ME; Melbye M; Wilson S; Ginzburg HM; Grossman RJ; DiGioia RA; Sanchez WC
    Science; 1986 Feb; 231(4741):992-5. PubMed ID: 3003917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key epidemiologic questions about AIDS and infection with HTLV-III/LAV.
    Hopkins DR
    Public Health Rep; 1986; 101(3):234-7. PubMed ID: 3012620
    [No Abstract]   [Full Text] [Related]  

  • 9. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
    Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
    JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS: a challenge for the public health.
    Acheson ED
    Lancet; 1986 Mar; 1(8482):662-6. PubMed ID: 2869356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acquired immunodeficiency syndrome in gay men.
    Jaffe HW; Hardy AM; Morgan WM; Darrow WW
    Ann Intern Med; 1985 Nov; 103(5):662-4. PubMed ID: 2996396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired immune deficiency syndrome: the causative agent and the evolving perspective.
    Fischinger PJ
    Curr Probl Cancer; 1985 Jan; 9(1):1-39. PubMed ID: 2983936
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS.
    Kalyanaraman VS; Cabradilla CD; Getchell JP; Narayanan R; Braff EH; Chermann JC; Barré-Sinoussi F; Montagnier L; Spira TJ; Kaplan J
    Science; 1984 Jul; 225(4659):321-3. PubMed ID: 6330889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of pediatric acquired immunodeficiency syndrome.
    Rubinstein A; Bernstein L
    Clin Immunol Immunopathol; 1986 Jul; 40(1):115-21. PubMed ID: 3013471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome.
    Kaplan JE; Oleske JM; Getchell JP; Kalyanaraman VS; Minnefor AB; Zabala-Ablan M; Joshi V; Denny T; Cabradilla CD; Rogers MF
    Pediatr Infect Dis; 1985; 4(5):468-71. PubMed ID: 2995933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV and HTLV-I infections in the Americas: a regional perspective.
    Quinn TC; Zacarias FR; St John RK
    Medicine (Baltimore); 1989 Jul; 68(4):189-209. PubMed ID: 2544782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
    JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human retroviruses in leukaemia and AIDS: reflections on their discovery, biology and epidemiology.
    Karpas A
    Biol Rev Camb Philos Soc; 2004 Nov; 79(4):911-33. PubMed ID: 15682876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of the prevalence of AIDS-associated virus (LAV) infection in Japan.
    Tsuchie H; Kurimura T; Hinuma Y
    J Infect; 1985 May; 10(3):272-6. PubMed ID: 2993425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.